MedTrace Logo

Oral Immunotherapy for Peanut and Mammalian Meat Allergies

NCT02350660 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2020-11-03

Study results available
· View outcomes & findings →

Summary

Pilot study to assess the effect of oral immunotherapy on specific Immunoglobulin E (IgE) levels and antigen consumption in two distinct food allergies.

Conditions

  • Food Hypersensitivity

Interventions

DIETARY_SUPPLEMENT

cow's milk

daily consumption of cow's milk

DIETARY_SUPPLEMENT

peanut powder

peanut oral immunotherapy

Sponsors & Collaborators

  • University of Virginia

    lead OTHER

Principal Investigators

  • Scott Commins, MD · University of Virginia

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
4 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2014-09-30
Completion
2015-06-30

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02350660 on ClinicalTrials.gov